ENYO Pharma
- Address
- 60 Avenue Rockefeller
Sponsor Overview
Specializations
Renal disease and kidney function
ENYO Pharma’s clinical research includes studies in Alport syndrome and in participants with impaired renal function, with attention to kidney-related outcomes in settings where renal decline is a major concern.
- Alport syndrome
- Renal impairment
- Kidney safety
The sponsor’s renal portfolio is centered on conditions where preservation of glomerular filtration and monitoring of renal tolerability are clinically important.
Metabolic liver disease
The company also studies suspected MASH, focusing on patients who present with metabolic and renal comorbidity and where liver-related disease burden intersects with reduced kidney function.
- MASH
- Metabolic dysfunction-associated steatohepatitis
- Hepatorenal involvement
This area reflects interest in therapeutic approaches relevant to metabolic liver disease alongside renal assessment.
Healthy volunteer pharmacology
ENYO Pharma includes healthy volunteers in its clinical research, supporting evaluation of pharmacokinetics and basic safety profiles for its investigational compounds.
- Pharmacokinetics
- Drug interaction assessment
- Early clinical safety
These studies are relevant to understanding how candidate therapies behave in the body before use in disease-focused populations.
Therapeutic development with vonafexor
Across its trials, the sponsor’s main therapeutic interest is centered on vonafexor, with research spanning renal disease, metabolic liver disease, and early human evaluation of its salt form, EYP651.
- Vonafexor
- EYP651
- Renal and metabolic indications
The clinical program links targeted pharmacology with disease areas where renal and metabolic pathways are both relevant.
Sponsored Trials
Data & Insights
This sponsor works with 3 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 11 sites across their trial portfolio.
Therapeutic Focus
- 1.Nutritional and Metabolic Diseases2 trials211 other sponsors
- 2.Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial165 other sponsors
- 3.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
11 centres- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- 1 Rue Jean Burguet, 33000 Bordeaux
- Address
- 80 Avenue Augustin Fliche, 34295 Montpellier
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- 1 Rue Des Essarts, 38610 Gieres
- Address
- Calle De Cartagena 340-350, 08025 Barcelona
Want to get in touch with this sponsor?
Send a question and we'll pass it on to ENYO Pharma.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.